Showing results (11-20 of 281) with videos related to
Sort By:
Pageof 29
Oncology Letters|February 20, 2018
miR-494 inhibits cervical cancer cell proliferation through upregulation of SOCS6 expressionLei Cheng, Beihua Kong, Ying Zhao, et al.Zhonghua Yi Xue Za Zhi|July 20, 2002
[Apoptosis of drug-resistant human ovarian carcinoma cell line 3AO/cDDP induced by arsenic trioxide and its mechanism]Shouguo Huang, Beihua Kong, Yuyan Ma, et al.Medicine|August 26, 2018
Antiangiogenesis therapy in ovarian cancer patients: An updated meta-analysis for 15 randomized controlled trialsYanyan Jiang, Xiaomei Sun, Beihua Kong, et al.Cellular & Molecular Biology Letters|May 23, 2021
MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancerXiaomei Sun, Lingtong Hou, Chunping Qiu, et al.Molecular Biology Reports|September 24, 2013
Analyze association of the progesterone receptor gene polymorphism PROGINS with ovarian cancer riskCunzhong Yuan, Cunfang Wang, Xiaoyan Liu, et al.International Journal of Oncology|February 19, 2014
Protection of ovarian function by GnRH agonists during chemotherapy: a meta-analysisXiaomei Sun, Samina Dongol, Jie Jiang, et al.Journal of Translational Medicine|June 8, 2019
Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathwayJun Dai, Rujia Wei, Peihai Zhang, et al.Cancer Biology & Therapy|December 5, 2009
Hepatocyte growth factor enhances ovarian cancer cell invasion through downregulation of thrombospondin-1Wei Wei, Beihua Kong, Qifeng Yang, et al.Clinical Chemistry and Laboratory Medicine|February 9, 2018
Prognostic value of HE4 in patients with ovarian cancerCunzhong Yuan, Rongrong Li, Shi Yan, et al.International Immunopharmacology|May 19, 2011
TLRs, macrophages, and NK cells: our understandings of their functions in uterus and ovaryZiyan Yang, Beihua Kong, David M Mosser, et al.Pageof 29